Fabrication of stem cell heterospheroids with sustained-release chitosan and poly(lactic-co-glycolic acid) microspheres to guide cell fate toward chondrogenic differentiation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nguyen, Tiep Tien | - |
dc.contributor.author | Kil, Yun-Seo | - |
dc.contributor.author | Sung, Jong-Hyuk | - |
dc.contributor.author | Youn, Yu Seok | - |
dc.contributor.author | Jeong, Ji Hoon | - |
dc.contributor.author | Lee, Jung Heon | - |
dc.contributor.author | Jiang, Hu-Lin | - |
dc.contributor.author | Yook, Simmyung | - |
dc.contributor.author | Nam, Joo-Won | - |
dc.contributor.author | Jeong, Jee-Heon | - |
dc.date.accessioned | 2024-04-29T00:00:25Z | - |
dc.date.available | 2024-04-29T00:00:25Z | - |
dc.date.issued | 2024-04 | - |
dc.identifier.issn | 0141-8130 | - |
dc.identifier.issn | 1879-0003 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/110516 | - |
dc.description.abstract | Mesenchymal stem cell (MSC)-based therapies show great potential in treating various diseases. However, control of the fate of injected cells needs to be improved. In this work, we developed an efficient methodology for modulating chondrogenic differentiation of MSCs. We fabricated heterospheroids with two sustained-release depots, a quaternized chitosan microsphere (QCS-MP) and a poly (lactic-co-glycolic acid) microsphere (PLGA-MP). The results show that heterospheroids composed of 1 × 104 to 5 × 104 MSCs formed rapidly during incubation in methylcellulose medium and maintained high cell viability in long-term culture. The MPs were uniformly distributed in the heterospheroids, as shown by confocal laser scanning microscopy. Incorporation of transforming growth factor beta 3 into QCS-MPs and of dexamethasone into PLGA-MPs significantly promoted the expression of chondrogenic genes and high accumulation of glycosaminoglycan in heterospheroids. Changes in crucial metabolites in the dual drug depot–engineered heterospheroids were also evaluated using 1H NMR-based metabolomics analysis to verify their successful chondrogenic differentiation. Our heterospheroid fabrication platform could be used in tissue engineering to study the effects of various therapeutic agents on stem cell fate. © 2024 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier B.V. | - |
dc.title | Fabrication of stem cell heterospheroids with sustained-release chitosan and poly(lactic-co-glycolic acid) microspheres to guide cell fate toward chondrogenic differentiation | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.ijbiomac.2024.130356 | - |
dc.identifier.scopusid | 2-s2.0-85186534650 | - |
dc.identifier.wosid | 001201947600001 | - |
dc.identifier.bibliographicCitation | International Journal of Biological Macromolecules, v.263 | - |
dc.citation.title | International Journal of Biological Macromolecules | - |
dc.citation.volume | 263 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Polymer Science | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Applied | - |
dc.relation.journalWebOfScienceCategory | Polymer Science | - |
dc.subject.keywordAuthor | Chondrogenesis | - |
dc.subject.keywordAuthor | Heterospheroid | - |
dc.subject.keywordAuthor | Stem cell | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.